Skip to content

The effects of thoracic manipulation for radiating leg pain

The effects of thoracic manipulation for impaired lower extremity neural dynamics

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN16968002
Enrollment
30
Registered
2024-09-26
Start date
2024-09-30
Completion date
Unknown
Last updated
2024-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of neural tension in the lower extremities in participants with radiating leg pain. Musculoskeletal Diseases

Interventions

The intervention consists of one 60-minute session per participant. Participants will be randomly assigned to one of two intervention groups utilizing a random number generator software program. This

Sponsors

Franklin Pierce University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Aged between 18-60 years old recruited from the community

Exclusion criteria

Exclusion criteria: 1. Ehler's Danlos and Marfan's Disease 2. The inability to provide verbal consent 3. Severe pain 4. Malignancy 5. Bone disease 6. Unhealed fractures or spinal fractures 7. Current infections 8. A history of deep vein thrombosis 9. Current pregnancy

Design outcomes

Primary

MeasureTime frame
Lower extremity neural tension range of motion is measured using a goniometer with the following standardized tests at baseline, immediately after the intervention, and 30 minutes post-intervention: 1. Knee extension range of motion with the slump test 2. Hip flexion range of motion with the passive straight leg raise test

Secondary

MeasureTime frame
1. Pain measured using a Visual Analog Scale (VAS) at baseline, immediately after the intervention, and 30 minutes post-intervention 2. Level of disability measured using the Oswestry Disability Index at baseline to categorize participants on the level of severity of their condition 3. Risk classification measured using Keele STarT at baseline to categorize patients on the level of severity of their condition

Countries

United States of America

Contacts

Public ContactTamara Hefferon
thefferon@impactptaz.com+1(0)480-298-0212

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026